Catalogue

Record Details

Catalogue Search


Back To Results
Showing Item 7 of 279

Prescribed drug spending in Canada, 2012 : a focus on public drug programs  Cover Image E-book E-book

Prescribed drug spending in Canada, 2012 : a focus on public drug programs

Record details

  • ISBN: 9781771092661
  • Physical Description: remote
    image/jpeg
    image/jpeg
    1 electronic text (ix, 47 pages) : illustrations.
  • Publisher: Ottawa, Ont. : Canadian Institute for Health Information, 2014.
  • Distributor: Ottawa, Ontario : Canadian Electronic Library, 2014.

Content descriptions

General Note:
Cover title.
Issued as part of the desLibris documents collection.
Bibliography, etc. Note: Includes bibliographical references (page 47).
Formatted Contents Note: Acknowledgements -- About CIHI -- Executive summary -- Highlights -- Introduction -- Prescribed drug spending in Canada: How much do Canadians spend on prescribed drugs? What are the trends in prescribed drug spending in Canada? What proportion of prescribed drug spending is funded by the public sector? -- Public Drug Program Spending in Selected Jurisdictions: Which drugs account for the highest proportion of public drug program spending? How is public drug program spending distributed? Which drugs contributed to the observed trends in public drug program spending? -- Appendix A: Glossary of terms -- Appendix B: Overview of drug program design and formulary -- Appendix C: Drug classification systems -- Appendix D: Factors that may influence drug use and expenditure in Canada -- Appendix E: Methodological notes -- Appendix F: Provincial and territorial drug programs -- Appendix G: Percentage of total public drug program spending, by broad therapeutic category, selected jurisdictions, 2012 -- Appendix H: Percentage of paid beneficiaries and total drug program spending, by program spending per paid beneficiary, selected jurisdictions, 2007 and 2012 -- Appendix I: Top 10 drug classes with the highest proportion of total program spending, by jurisdiction, 2012 -- References.
System Details Note:
Mode of access: World Wide Web.
Subject: Drugs -- Costs -- Canada -- Statistics
Pharmaceutical policy -- Canada
Pharmaceutical services insurance -- Canada
Economics, Pharmaceutical -- Canada
Drug Costs -- Canada -- statistics & numerical data
Pharmaceutical Services insurance -- Canada
Costs and Cost Analysis -- Canada -- statistics & numerical data
Médicaments -- Coût -- Canada -- Statistiques
Médicaments -- Politique gouvernementale -- Canada
Assurance-médicaments -- Canada
Coût médicament -- Statistiques et données numériques -- Canada
Économie pharmaceutique -- Canada
Assurance concernant les frais pharmaceutiques -- Canada
Antidepressant
Canada
Canadian institute for health information
Chronic condition
Chronic obstructive pulmonary disease
Clinical medicine
First nations
Generic drug
Health
Health care
Antidepressants
Canadian institute for health information
Economy, business and finance -- Economic sector -- Chemicals
Economy, business and finance -- Economic sector -- Chemicals -- Pharmaceutical
Health
Health -- Diseases and conditions -- Cancer
Health -- Health treatment
Health -- Health treatment -- Medical drugs
Health -- Health treatment -- Medical drugs -- Prescription drugs
Health -- Health treatment -- Medicine
Health -- Health treatment -- Therapy
Health -- Healthcare policy -- Government health care
Hmg-coa reductase inhibitors
Province
Province and territory
Provinces
Provincial
Provincial and territorial
Provincial governments
Selective serotonin reuptake inhibitors
Genre: Electronic books.

Electronic resources


Back To Results
Showing Item 7 of 279

Additional Resources